Dr. Leger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Stop MB8
Seattle, WA 98105Phone+1 206-987-5509Fax+1 206-987-3964
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2010 - 2013
- University of ColoradoResidency, Pediatrics, 2006 - 2009
- McGovern Medical School at UTHealthClass of 2006
Certifications & Licensure
- WA State Medical License 2014 - 2025
- TX State Medical License 2013 - 2014
- CO State Medical License 2009 - 2011
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment Start of enrollment: 2014 Mar 05
Publications & Presentations
PubMed
- -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy.Sara K Silbert, Samantha Scanlon, Hao-Wei Wang, Constance M Yuan, Alyssa Doverte
Journal for Immunotherapy of Cancer. 2024-10-26 - Progress Toward Cardiac Risk Reduction With the Evolution of Pediatric Hodgkin Lymphoma Therapy.Kasey J Leger, Hari K Narayan
JAMA Network Open. 2024-01-02 - Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side-by-side comparison.Sarah Menig, Andrew Dinh, Jonathan Angus, Sarah Tucker, Kasey J Leger
Pediatric Blood & Cancer. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: